Oncopeptides AB (ONPPF)
0.265
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Oncopeptides EPS Diluted (Quarterly): -0.0417 for Sept. 30, 2023
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.0417 |
| June 30, 2023 | -0.059 |
| March 31, 2023 | -0.0758 |
| December 31, 2022 | -0.0946 |
| September 30, 2022 | -0.0954 |
| June 30, 2022 | -0.0807 |
| March 31, 2022 | -0.1406 |
| December 31, 2021 | -0.5356 |
| September 30, 2021 | -1.196 |
| June 30, 2021 | -0.0381 |
| March 31, 2021 | -0.412 |
| December 31, 2020 | -0.8955 |
| September 30, 2020 | -0.645 |
| June 30, 2020 | -0.7024 |
| March 31, 2020 | -0.5584 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.4614 |
| September 30, 2019 | -0.3683 |
| June 30, 2019 | -0.3727 |
| March 31, 2019 | -0.0031 |
| December 31, 2018 | -0.2819 |
| September 30, 2018 | -0.2393 |
| June 30, 2018 | -0.3812 |
| March 31, 2018 | -0.1925 |
| December 31, 2017 | -0.1995 |
| September 30, 2017 | -0.16 |
| June 30, 2017 | -0.1919 |
| March 31, 2017 | -0.2118 |
| December 31, 2016 | -0.1767 |
| September 30, 2016 | -0.0746 |
| June 30, 2016 | -0.0737 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-1.196
Minimum
Sep 2021
-0.0381
Maximum
Jun 2021
-0.3763
Average
-0.3705
Median
EPS Diluted (Quarterly) Benchmarks
| Abliva AB | -0.0019 |
| Karolinska Development AB | 0.0001 |
| Calliditas Therapeutics AB | -0.064 |
| Olink Holding AB | -0.13 |
| BioInvent International AB | -0.1138 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.758M |
| Revenue (Quarterly) | 0.26M |
| Total Expenses (Quarterly) | 3.718M |
| Enterprise Value | 12.46M |
| Profit Margin (Quarterly) | -1.45K% |
| Earnings Yield | -102.3% |
| Normalized Earnings Yield | -102.29 |